Rhythm Biosciences Ltd

ASX:RHY (Australia)   Ordinary Shares
A$ 0.08 (+3.7%) Dec 24
At Loss
P/B:
28.00
Market Cap:
A$ 20.88M ($ 13.00M)
Enterprise V:
A$ 20.29M ($ 12.63M)
Volume:
526.63K
Avg Vol (2M):
395.84K
Trade In:
Volume:
526.63K
At Loss
Avg Vol (2M):
395.84K

Business Description

Rhythm Biosciences Ltd

ISIN : AU000000RHY2

Share Class Description:

ASX:RHY: Ordinary Shares
Description
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 4.63
Equity-to-Asset 0.57
Debt-to-Equity 0.19
Debt-to-EBITDA -0.02
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.89
9-Day RSI 42.73
14-Day RSI 42.36
6-1 Month Momentum % 94.03
12-1 Month Momentum % 6.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.58
Quick Ratio 1.58
Cash Ratio 1.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.3
Shareholder Yield % -14.02

Profitability Rank

Name Current Vs Industry Vs History
ROE % -257.62
ROA % -184.33
ROIC % -489.82
ROC (Joel Greenblatt) % -1111.3
ROCE % -252.23

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 28
EV-to-EBIT -2.96
EV-to-EBITDA -3.05
EV-to-FCF -3.26
Earnings Yield (Greenblatt) % -33.78
FCF Yield % -29.79

Financials

ASX:RHY's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rhythm Biosciences Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.03
Beta 1
Volatility % 76.31
14-Day RSI 42.36
14-Day ATR (A$) 0.005816
20-Day SMA (A$) 0.0868
12-1 Month Momentum % 6.23
52-Week Range (A$) 0.042 - 0.181118
Shares Outstanding (Mil) 283.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rhythm Biosciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Rhythm Biosciences Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Rhythm Biosciences Ltd Frequently Asked Questions

What is Rhythm Biosciences Ltd(ASX:RHY)'s stock price today?
The current price of ASX:RHY is A$0.08. The 52 week high of ASX:RHY is A$0.18 and 52 week low is A$0.04.
When is next earnings date of Rhythm Biosciences Ltd(ASX:RHY)?
The next earnings date of Rhythm Biosciences Ltd(ASX:RHY) is .
Does Rhythm Biosciences Ltd(ASX:RHY) pay dividends? If so, how much?
Rhythm Biosciences Ltd(ASX:RHY) does not pay dividend.

Press Release

Subject Date
No Press Release